Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDM
2851
Piedmont Realty Trust
PDM
$1.19B
| $6.58M | ﹤0.01% |
622,677
-214,645
| -26% | -$2.69M |
|
|
ZUO
2852
DELISTED
Zuora, Inc.
ZUO
| $6.56M | ﹤0.01% |
888,465
+261,449
| +42% | +$2.25M |
|
|
ITOS
2853
DELISTED
iTeos Therapeutics
ITOS
| $6.55M | ﹤0.01% |
343,601
-67,470
| -16% | -$1.55M |
|
2854
Vermilion Energy
VET
$1.66B
| $6.54M | ﹤0.01% |
305,402
| – | – |
|
2855
CALL
United States Oil Fund
USO
$1.84B
| $6.53M | ﹤0.01% |
100,000
-9,900
| -9% | -$724K |
|
2856
CALL
Constellation Brands
STZ
$23.2B
| $6.52M | ﹤0.01% |
28,400
+20,000
| +238% | +$4.87M |
|
2857
Nerdy
NRDY
$96.7M
| $6.52M | ﹤0.01% |
3,091,308
-896,254
| -22% | -$2.4M |
|
|
WE
2858
DELISTED
WeWork Inc.
WE
| $6.5M | ﹤0.01% |
61,282
+85
| +0.1% | +$15.3K |
|
2859
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $6.49M | ﹤0.01% |
236,146
-16,181
| -6% | -$441K |
|
2860
Helios Technologies
HLIO
$2.76B
| $6.49M | ﹤0.01% |
128,233
+102,414
| +397% | +$6.19M |
|
2861
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$516M
| $6.49M | ﹤0.01% |
131,305
+21,826
| +20% | +$1.13M |
|
2862
Hamilton Lane
HLNE
$5.57B
| $6.49M | ﹤0.01% |
108,805
-10,266
| -9% | -$725K |
|
2863
PUT
Occidental Petroleum
OXY
$55.9B
| $6.48M | ﹤0.01% |
105,500
+95,500
| +955% | +$6.11M |
|
2864
CVR Partners
UAN
$1.34B
| $6.48M | ﹤0.01% |
56,658
+41,759
| +280% | +$4.77M |
|
2865
Fresenius Medical Care
FMS
$12.9B
| $6.46M | ﹤0.01% |
459,970
+285,772
| +164% | +$5.4M |
|
2866
Vanguard Consumer Staples ETF
VDC
$7.99B
| $6.45M | ﹤0.01% |
37,537
-22,566
| -38% | -$4.26M |
|
2867
AngioDynamics
ANGO
$649M
| $6.43M | ﹤0.01% |
314,261
+69,888
| +29% | +$1.53M |
|
2868
PUT
XP
XP
$8.39B
| $6.43M | ﹤0.01% |
338,000
-2,790,000
| -89% | -$55.4M |
|
2869
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$495M
| $6.42M | ﹤0.01% |
171,304
| – | – |
|
2870
Viper Energy
VNOM
$14.7B
| $6.42M | ﹤0.01% |
223,967
+93,141
| +71% | +$2.71M |
|
|
FMTX
2871
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $6.42M | ﹤0.01% |
321,553
+135,211
| +73% | +$1.78M |
|
|
ATEK
2872
DELISTED
Athena Technology Acquisition Corp. II
ATEK
| $6.39M | ﹤0.01% |
648,870
+638,232
| +6,000% | +$6.29M |
|
2873
Pacira BioSciences
PCRX
$997M
| $6.39M | ﹤0.01% |
120,082
+10,973
| +10% | +$610K |
|
2874
Protagonist Therapeutics
PTGX
$9.44B
| $6.38M | ﹤0.01% |
757,079
+125,163
| +20% | +$1.18M |
|
2875
Talkspace
TALK
$874M
| $6.37M | ﹤0.01% |
6,186,106
+1,868,014
| +43% | +$2.74M |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.